Anna Lord

1.5k citations
15 papers · 1.2k indexed · h-index 15
Topics
Alzheimer's disease research and treatments (11 papers)Prion Diseases and Protein Misfolding (8 papers)Nuclear Receptors and Signaling (3 papers)

In The Last Decade

Anna Lord

15 papers receiving 1.1k citations

Peers

Anna Lord
Comparison fields: 5 of 71
  • Physiology 869
  • Molecular Biology 444
  • Cellular and Molecular Neuroscience 263
  • Pharmacology 225
  • Computational Theory and Mathematics 219
Replace Luisa Onstead with:
Luisa Onstead United States
Charlotte Forsell Sweden
Karen Khan United States
Yasushi Tomidokoro Japan
Asa Hatami United States
Fiona Pickford United States
Branislav Kováčech Slovakia
Sethu Sankaranarayanan United States
Brenda D. Moore United States
Paul Fraser Canada
Anna Lord relative to Luisa Onstead United States Luisa Onstead's profile →
Citations per field
00.5×3.1×
Luisa Onstead · 1×
Citations per year

Countries citing papers authored by Anna Lord

Since Specialization
Citations

This map shows the geographic impact of Anna Lord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lord more than expected).

Fields of papers citing papers by Anna Lord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lord. The network helps show where Anna Lord may publish in the future.

Co-authorship network of co-authors of Anna Lord

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lord. A scholar is included among the top collaborators of Anna Lord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lord. Anna Lord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 106
2 200
3 74
4 33
5 31
6 80
7 32
8 35
9 78
10 107
11 53
12 88
13 207
14 20
15 22

About Anna Lord

Anna Lord is a scholar working on Physiology, Physiology and Cellular and Molecular Neuroscience, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (11 papers), Prion Diseases and Protein Misfolding (8 papers) and Nuclear Receptors and Signaling (3 papers). The work is most often cited by research in Physiology (869 citations), Neurology (208 citations) and Biological Psychiatry (57 citations). Anna Lord has collaborated with scholars based in Sweden, United States and Finland. Frequent co-authors include Lars Lannfelt, Lars Nilsson, Pär Gellerfors, Hannu Kalimo, Hillevi Englund, Christer Möller, Xiaoqun Zhang, Chris Eckman, Stina Tucker and Linda Söderberg. Their work appears in journals such as Annals of Neurology, Journal of Neurochemistry and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026